Results
Supriya Lifescience Q2 Revenue Up 3.2% YoY
• Transcript discloses Q2 FY27 revenue of ₹206 crore, up 3.2% YoY, but EBITDA fell 37.5% to ₹45 crore.
• Management revises FY27 EBITDA margin guidance down to 23-25% due to LATAM regulatory changes,
